drugset / Trial / NCT07413133
A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers
RandomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to assess the pharmacokinetics (PK), bioavailability, immunogenicity, safety, and tolerability of ABBV-8736 following subcutaneous (SC) administration relative to intravenous (IV) administration.
Timeline
- Start
- 2026-02-11
- Primary completion
- 2026-06-19
- Completion
- 2026-06-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-8736 | Unknown | — | Intravenous |
Indications
No indication recorded.